PECAM1 and B-cell chronic lymphocytic leukemia: We first explored expression of the CD38 ligand CD31 and found constitutive expression in both CLL and Th cells (Figures S4A–S4C), with higher CD31 expression in CLL cells compared to Th cells (Figure S4D), confirming the presence of an agonist for CD38 receptor activation.